首页> 外文期刊>Phytotherapy research: PTR >Evidence of Effectiveness of Herbal Medicinal Products in the Treatment of Arthritis Part 2: Rheumatoid Arthritis
【24h】

Evidence of Effectiveness of Herbal Medicinal Products in the Treatment of Arthritis Part 2: Rheumatoid Arthritis

机译:草药治疗关节炎的有效性证据第2部分:类风湿关节炎

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Herbal medicinal products (HMPs) that interact with the mediators of inflammation are used in the treatmentof rheumatoid arthritis (RA). The aim of this study was to update a previous systematic review published in2000. We searched electronic databases (MEDLINE, EMBASE, CISCOM, AMED, CINAHL, Cochrane reg-isters) to June 2007, unrestricted by date or language, and included randomized controlled trials that comparedHMPs with inert (placebo) or active controls in patients with rheumatoid arthritis. Five reviewers contributedto data extraction. Disagreements were discussed and resolved by consensus with reference to Cochrane guide-lines and advice from the Cochrane Collaboration. Twenty studies (10 identified for this review update, and 10 of the 11 studies of the original review) investi-gating 14 HMPs were included. Meta-analysis was restricted to data from previous seven studies with oils fromborage, blackcurrant and evening primrose containing gamma linolenic acid (GLA). GLA doses equal or higherthan 1400 mg/day showed benefit in the alleviation of rheumatic complaints whereas lower doses (-500 mg)were ineffective. Three studies compared products from Tripterygium wilfordii (thunder god vine) to placebosand returned favorable results but data could not be pooled because the interventions and measures differed.Serious adverse effects occurred in one study. In a follow-up study all side effects were mild to moderate andresolved after the intervention ceased, but time to resolution was variable. Two studies comparing PhytodolorNR to placebo were of limited use because some measures were poorly defined. The remaining studies, eachconsidering differing HMPs, were assessed individually. For most HMPs used in the treatment of RA, the evidence of effectiveness was insufficient to either recom-mend or discourage their use. Interventions with HMPs containing GLA or Tripterygium wilfordii extractappear to produce therapeutic effects but further investigations are warranted to prove their effectiveness andsafety
机译:与炎症介质相互作用的草药(HMP)用于治疗类风湿关节炎(RA)。本研究的目的是更新以前于2000年发表的系统综述。我们搜索了截至2007年6月的电子数据库(MEDLINE,EMBASE,CISCOM,AMED,CINAHL,Cochrane登记处),不受日期或语言的限制,并纳入了随机对照试验,比较了类风湿关节炎患者中将HMP与惰性(安慰剂)或有效对照进行比较。五位审稿人为数据提取做出了贡献。通过参考Cochrane准则和Cochrane合作组织的建议,以协商一致的方式讨论和解决了分歧。包括20项研究(确定10项针对该评价的更新,以及11项原始评价的研究中的10项),研究了14种HMP。荟萃分析仅限于来自前七项研究的数据,这些研究使用的是来自含伽马亚麻酸(GLA)的琉璃苣,黑加仑和月见草油。等于或高于1400毫克/天的GLA剂量在减轻风湿性不适方面显示出益处,而较低的剂量(-500毫克)无效。三项研究比较了雷公藤(雷公藤)与安慰剂的产品,返回了满意的结果,但由于干预措施和措施不同,无法汇总数据。一项研究发生了严重的不良反应。在一项后续研究中,所有副作用均为轻度至中度,并在干预停止后可缓解,但解决的时间可变。两项将PhytodolorNR与安慰剂进行比较的研究用途有限,因为某些措施定义不明确。其余的研究,每个都考虑到不同的HMP,要分别评估。对于大多数用于RA治疗的HMP,有效性的证据不足以建议或不鼓励其使用。含有GLA或雷公藤提取物的HMP的干预似乎可产生治疗效果,但仍需进一步研究以证明其有效性和安全性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号